Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag

Virology

Volumn 360, Issue 1, 2007, Pages 27-35

  Ono, Akira ^a,b   Waheed, Abdul A ^a   Freed, Eric O ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cholesterol; Gag; HIV 1; Lipid raft; Membrane binding; Myristyl switch; Retrovirus assembly

Indexed keywords

CHOLESTEROL; GAG PROTEIN;

ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPID RAFT; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LIPID INTERACTION; PROTEIN POLYMERIZATION; VIRUS ASSEMBLY; VIRUS CELL INTERACTION;

CHOLESTEROL; GENE PRODUCTS, GAG; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; MEMBRANE MICRODOMAINS; PROTEIN BINDING; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33847254050     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.10.011     Document Type: Article

References (68)

1. Adamson C.S., and Jones I.M. The molecular basis of HIV capsid assembly-five years of progress. Rev. Med. Virol. 14 (2004) 107-121
2. Aloia R.C., Tian H., and Jensen F.C. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 5181-5185
3. Briggs J.A., Wilk T., and Fuller S.D. Do lipid rafts mediate virus assembly and pseudotyping?. J. Gen. Virol. 84 (2003) 757-768
4. Brown D.A., and London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275 (2000) 17221-17224
5. Brown D.A., and Rose J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68 (1992) 533-544
6. Brugger B., Glass B., Haberkant P., Leibrecht I., Wieland F.T., and Krausslich H.G. The HIV lipidome: a raft with an unusual composition. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 2641-2646
7. Dalton A.K., Murray P.S., Murray D., and Vogt V.M. Biochemical characterization of Rous sarcoma virus MA protein interaction with membranes. J. Virol. 79 (2005) 6227-6238
8. Demirov D.G., and Freed E.O. Retrovirus budding. Virus Res. 106 (2004) 87-102
9. Ding L., Derdowski A., Wang J.J., and Spearman P. Independent segregation of human immunodeficiency virus type 1 Gag protein complexes and lipid rafts. J. Virol. 77 (2003) 1916-1926
10. Edidin M. The state of lipid rafts: from model membranes to cells. Annu. Rev. Biophys. Biomol. Struct. 32 (2003) 257-283
11. Feng X., Heyden N.V., and Ratner L. Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts. J. Virol. 77 (2003) 13389-13395
12. Freed E.O. HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 251 (1998) 1-15
13. Freed E.O., and Martin M.A. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120. J. Virol. 68 (1994) 2503-2512
14. Freed E.O., Orenstein J.M., Buckler-White A.J., and Martin M.A. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68 (1994) 5311-5320
15. Grigorov B., Arcanger F., Roingeard P., Darlix J.L., and Muriaux D. Assembly of infectious HIV-1 in human epithelial and T-lymphoblastic cell lines. J. Mol. Biol. 359 (2006) 848-862
16. Guo X., Roldan A., Hu J., Wainberg M.A., and Liang C. Mutation of the SP1 sequence impairs both multimerization and membrane-binding activities of human immunodeficiency virus type 1 Gag. J. Virol. 79 (2005) 1803-1812
17. Halwani R., Khorchid A., Cen S., and Kleiman L. Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1. J. Virol. 77 (2003) 3973-3984
18. Harder T., Scheiffele P., Verkade P., and Simons K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol. 141 (1998) 929-942
19. Heerklotz H. Triton promotes domain formation in lipid raft mixtures. Biophys. J. 83 (2002) 2693-2701
20. Hermida-Matsumoto L., and Resh M.D. Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA. J. Virol. 73 (1999) 1902-1908
21. Hermida-Matsumoto L., and Resh M.D. Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J. Virol. 74 (2000) 8670-8679
22. Holm K., Weclewicz K., Hewson R., and Suomalainen M. Human immunodeficiency virus type 1 assembly and lipid rafts: Pr55(gag) associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100. J. Virol. 77 (2003) 4805-4817
23. Huang M., Orenstein J.M., Martin M.A., and Freed E.O. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69 (1995) 6810-6818
24. Jolly C., and Sattentau Q.J. Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity. J. Virol. 79 (2005) 12088-12094
25. Kwik J., Boyle S., Fooksman D., Margolis L., Sheetz M.P., and Edidin M. Membrane cholesterol, lateral mobility, and the phosphatidylinositol 4,5-bisphosphate-dependent organization of cell actin. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13964-13969
26. Lindwasser O.W., and Resh M.D. Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J. Virol. 75 (2001) 7913-7924
27. Lindwasser O.W., and Resh M.D. Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 13037-13042
28. Morita E., and Sundquist W.I. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20 (2004) 395-425
29. Munro S. Lipid rafts: elusive or illusive?. Cell 115 (2003) 377-388
30. Nguyen D.H., and Hildreth J.E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74 (2000) 3264-3272
31. Nydegger S., Foti M., Derdowski A., Spearman P., and Thali M. HIV-1 egress is gated through late endosomal membranes. Traffic 4 (2003) 902-910
32. Ono A., and Freed E.O. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. J. Virol. 73 (1999) 4136-4144
33. Ono A., and Freed E.O. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13925-13930
34. Ono A., and Freed E.O. Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body. J. Virol. 78 (2004) 1552-1563
35. Ono A., and Freed E.O. The role of lipid rafts in virus replication. In: Roy P. (Ed). Advances in Virus Research, Virus Structure and Assembly (2005), Elsevier 64 vols
36. Ono A., Demirov D., and Freed E.O. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding. J. Virol. 74 (2000) 5142-5150
37. Ono A., Orenstein J.M., and Freed E.O. Role of the gag matrix domain in targeting human immunodeficiency virus type 1 assembly. J. Virol. 74 (2000) 2855-2866
38. Ono A., Ablan S.D., Lockett S.J., Nagashima K., and Freed E.O. Phosphatidylinositol(4,5)bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 14889-14894
39. Ono A., Waheed A.A., Joshi A., and Freed E.O. Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assay. J. Virol. 79 (2005) 14131-14140
40. Paillart J.C., and Gottlinger H.G. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting. J. Virol. 73 (1999) 2604-2612
41. Panchal R.G., Ruthel G., Kenny T.A., Kallstrom G.H., Lane D., Badie S.S., Li L., Bavari S., and Aman M.J. In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 15936-15941
42. Pelchen-Matthews A., Kramer B., and Marsh M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 162 (2003) 443-455
43. Perez-Caballero D., Hatziioannou T., Martin-Serrano J., and Bieniasz P.D. Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on gag precursor-membrane interactions. J. Virol. 78 (2004) 9560-9563
44. Perlman M., and Resh M.D. Identification of an intracellular trafficking and assembly pathway for HIV-1 gag. Traffic 7 (2006) 731-745
45. Pickl W.F., Pimentel-Muinos F.X., and Seed B. Lipid rafts and pseudotyping. J. Virol. 75 (2001) 7175-7183
46. Raposo G., Moore M., Innes D., Leijendekker R., Leigh-Brown A., Benaroch P., and Geuze H. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 3 (2002) 718-729
47. Rodal S.K., Skretting G., Garred O., Vilhardt F., van Deurs B., and Sandvig K. Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol. Biol. Cell 10 (1999) 961-974
48. Rudner L., Nydegger S., Coren L.V., Nagashima K., Thali M., and Ott D.E. Dynamic fluorescent imaging of human immunodeficiency virus type 1 gag in live cells by biarsenical labeling. J. Virol. 79 (2005) 4055-4065
49. Saad J.S., Miller J., Tai J., Kim A., Ghanam R.H., and Summers M.F. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 11364-11369
50. Gag. J. Virol. 72 (1998) 2723-2732
51. Sandefur S., Smith R.M., Varthakavi V., and Spearman P. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag). J. Virol. 74 (2000) 7238-7249
52. Sherer N.M., Lehmann M.J., Jimenez-Soto L.F., Ingmundson A., Horner S.M., Cicchetti G., Allen P.G., Pypaert M., Cunningham J.M., and Mothes W. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 4 (2003) 785-801
53. Shkriabai N., Datta S.A., Zhao Z., Hess S., Rein A., and Kvaratskhelia M. Interactions of HIV-1 Gag with assembly cofactors. Biochemistry 45 (2006) 4077-4083
54. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat. Rev., Mol. Cell Biol. 1 (2000) 31-39
55. Simons K., and Vaz W.L. Model systems, lipid rafts, and cell membranes. Annu. Rev. Biophys. Biomol. Struct. 33 (2004) 269-295
56. Spearman P., Horton R., Ratner L., and Kuli-Zade I. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J. Virol. 71 (1997) 6582-6592
57. Srinivasakumar N., Chazal N., Helga-Maria C., Prasad S., Hammarskjold M.L., and Rekosh D. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines. J. Virol. 71 (1997) 5841-5848
58. Subtil A., Gaidarov I., Kobylarz K., Lampson M.A., Keen J.H., and McGraw T.E. Acute cholesterol depletion inhibits clathrin-coated pit budding. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 6775-6780
59. Suomalainen M. Lipid rafts and assembly of enveloped viruses. Traffic 3 (2002) 705-709
60. Swanstrom R., and Wills J.W. Synthesis, assembly, and processing of viral proteins. In: Coffin J.M., Hughes S.H., and Varmus H.E. (Eds). Retroviruses (1997), Cold Spring Harbor Laboratory Press, New York 263-334
61. Takeda M., Leser G.P., Russell C.J., and Lamb R.A. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 14610-14617
62. Tang C., Loeliger E., Luncsford P., Kinde I., Beckett D., and Summers M.F. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 517-522
63. 2-terminal myristoylation and palmitoylation at cysteine-3. J. Cell Biol. 136 (1997) 1023-1035
64. Yang L., and Ratner L. Interaction of HIV-1 gag and membranes in a cell-free system. Virology 302 (2002) 164-173
65. Yee J.K., Friedmann T., and Burns J.C. Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol. 43 Pt. (1994) 99-112
66. Yuan X., Yu X., Lee T.H., and Essex M. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J. Virol. 67 (1993) 6387-6394
67. Zhou W., and Resh M.D. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70 (1996) 8540-8548
68. Zhou W., Parent L.J., Wills J.W., and Resh M.D. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68 (1994) 2556-2569